Evolocumab Alters Vascular Function in Patients With Cardiovascular Disease

被引：0
|
作者：
Kannenkeril, Dennis
Bosch, Agnes
Striepe, Kristina
Berner, Laura
Pietschner, Robert
Kolwelter, Julie
Ott, Christian
Schiffer, Mario
Achenbach, Stephan
Schmieder, Roland E.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13958
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evolocumab in Patients with Cardiovascular Disease
    Koskinas, Konstantinos C.
    Windecker, Stephan
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (08): : 786 - 786
  • [2] Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
    Sabatine, Marc S.
    Giugliano, Robert P.
    Keech, Anthony C.
    Honarpour, Narimon
    Wiviott, Stephen D.
    Murphy, Sabina A.
    Kuder, Julia F.
    Wang, Huei
    Liu, Thomas
    Wasserman, Scott M.
    Sever, Peter S.
    Pedersen, Terje R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18): : 1713 - 1722
  • [3] comment on "Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease"
    Costa, Marco
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2017, 36 (06) : 485 - 486
  • [4] Evolocumab for Patients with cardiovascular Disease First clinical Outcome Data
    Chakaroun, R.
    DIABETOLOGE, 2017, 13 (04): : 272 - 273
  • [5] Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    O'Donoghue, Michelle L.
    Giugliano, Robert P.
    Wiviott, Stephen D.
    Atar, Dan
    Keech, Anthony
    Kuder, Julia F.
    Im, KyungAh
    Murphy, Sabina A.
    Flores-Arredondo, Jose H.
    Lopez, J. Antonio G.
    Elliott-Davey, Mary
    Wang, Bei
    Monsalvo, Maria Laura
    Abbasi, Siddique
    Sabatine, Marc S.
    CIRCULATION, 2022, 146 (15) : 1109 - 1119
  • [6] Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    O'Donoghue, Michelle L.
    Giugliano, Robert P.
    Sabatine, Marc S.
    CIRCULATION, 2023, 147 (16) : 1258 - 1259
  • [7] Evolocumab reduces cardiovascular events in patients with heart disease, finds study
    Mayor, Susan
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 356
  • [8] Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
    Fonarow, Gregg C.
    Keech, Anthony C.
    Pedersen, Terje R.
    Giugliano, Robert P.
    Sever, Peter S.
    Lindgren, Peter
    van Hout, Ben
    Villa, Guillermo
    Qian, Yi
    Somaratne, Ransi
    Sabatine, Marc S.
    JAMA CARDIOLOGY, 2017, 2 (10) : 1069 - 1078
  • [9] Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia
    Garcia-Pena, Angel Alberto
    Pineda-Posada, Mariana
    Paez-Canro, Carol
    Cruz, Cesar
    Samaca-Samaca, Daniel
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (06): : 280 - 289
  • [10] Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
    Gregoire, Jean
    Champsi, Salimah
    Jobin, Manon
    Martinez, Laura
    Urbich, Michael
    Rogoza, Raina M.
    ADVANCES IN THERAPY, 2022, 39 (07) : 3262 - 3279
12345